Medicare Enrolled

Dr. Joseph Boss, M.D.

Ophthalmology · Grand Rapids, MI
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
5030 CASCADE RD SE, Grand Rapids, MI 49546
6169542020
Registered in NPPES since 2013
NPI: 1912346388 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Boss from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Boss? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Boss

Dr. Joseph Boss is an ophthalmology specialist in Grand Rapids, MI, with 13 years of NPI registration. Based on federal Medicare data, Dr. Boss performed 3,426 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Boss received a total of $20,618 from 25 pharmaceutical and/or device companies across 146 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Boss is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years of NPI registration ▲ Top 19% volume in MI $20,618 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
3,426
Medicare services
Top 19% in MI for ophthalmology
Not available
Unique patients (not deduplicated)
$222
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
1,004 $27 $75
Aflibercept eye injection (Eylea) 874 $686 $1,250
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
628 $92 $257
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
234 $81 $180
Unclassified biologic
A biologic product that does not have a specific HCPCS code assigned.
222 $75 $200
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
213 $88 $150
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
84 $26 $150
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
63 $117 $245
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
24 $124 $210
Fluorescein angiography of retina
A special camera captures images of the blood vessels in the retina and the area between the white part of the eye and the retina after a dye is injected.
23 $181 $428
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
16 $34 $150
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
16 $97 $191
Retinal photocoagulation to prevent detachment
This procedure uses laser light to create small burns on the retina. It is performed to help prevent the retina from detaching from the back of the eye.
13 $164 $1,230
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
12 $57 $100
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$20,618
Total received (2018-2024)
Avg $2,945/year across 7 years
Top 5% in MI for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
146
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,509
2023
$4,906
2022
$1,647
2021
$2,337
2020
$5,507
2019
$442
2018
$2,270

Payments by company (2024)

Alimera Sciences, Inc.
$2,823
Regeneron Healthcare Solutions, Inc.
$238
Apellis Pharmaceuticals, Inc.
$127
Bausch & Lomb Americas Inc.
$61
Biogen, Inc.
$60
ANI Pharmaceuticals, Inc.
$47
Amgen Inc.
$44
Mallinckrodt Hospital Products Inc.
$42
Genentech USA, Inc.
$27
Astellas Pharma US Inc
$25
ABBVIE INC.
$15
Top 3 companies account for 90.8% of 2024 payments
All-time payments by company (2018-2024) ›
Alimera Sciences, Inc.
$7,361
Bausch & Lomb, a division of Bausch Health US, LLC
$5,611
Regeneron Pharmaceuticals, Inc.
$1,956
EyePoint Pharmaceuticals US, Inc.
$1,762
US Retina LLC
$1,517
Bausch & Lomb Americas Inc.
$516
Regeneron Healthcare Solutions, Inc.
$455
Allergan Inc.
$260
Apellis Pharmaceuticals, Inc.
$231
Coherus Biosciences Inc.
$148
Genentech USA, Inc.
$141
Novartis Pharmaceuticals Corporation
$137
Biogen, Inc.
$114
Mallinckrodt Hospital Products Inc.
$62
Mallinckrodt Enterprises LLC
$55
ANI Pharmaceuticals, Inc.
$47
AbbVie Inc.
$46
Amgen Inc.
$44
Allergan, Inc.
$43
Alcon Laboratories Inc
$28
Astellas Pharma US Inc
$25
TISSUETECH, INC.
$16
ABBVIE INC.
$15
BioTissue Holdings, Inc.
$15
AbbVie, Inc.
$12
Top 3 companies account for 72.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BEOVU · BYOOVIZ · Cimerli · Constellation · DURYSTA · EYLEA · EYLEA HD · HUMIRA · Humira · ILUVIEN · Iluvien · Izervay · OZURDEX · PROKERA · PURIFIED CORTROPHIN GEL · RETISERT · STELLARIS · STELLARIS PC · SUSVIMO · Syfovre · TEPEZZA · VABYSMO · VISUDYNE · Vabysmo · XIPERE · YUTIQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an ophthalmology specialist in Grand Rapids?
Compare ophthalmologists in the Grand Rapids area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists in nearby ZIP areas
59
County median income
$80,390
Nearest hospital to ZIP centroid (approximate)
FOREST VIEW PSYCHIATRIC HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Boss is a mixed practice specialist, with above-average Medicare volume (top 19% in MI).

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Boss experienced with retinal imaging (oct scan)?
Based on Medicare claims data, Dr. Boss performed 1,004 retinal imaging (oct scan) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Boss receive payments from pharmaceutical companies?
Yes. Dr. Boss received a total of $20,618 from 25 companies across 146 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Boss's costs compare to other ophthalmologists in Grand Rapids?
Dr. Boss's average Medicare payment per service is $222. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Boss) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →